SONOCO PRODUCTS CO
In the published model solve dated 2026-Q2, anchored at $58.45, SONOCO PRODUCTS CO (SON) is priced for -4.5% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 11, 2026 from SEC EDGAR filings.
• Sonoco has spent two years swapping businesses: the Eviosys metal-can acquisition came in, the thermoformed-flexibles and ThermoSafe units went out as discontinued operations [FY2025 10-K, accession 0000091767-26-000008], and the result is a global consumer and industrial packaging company operating across 37 countries priced at $55.91 (July 10, 2026), roughly half of what most of the valuation lenses would defend. • The biggest specific risk is the balance sheet meeting a soft cycle: $4.5 bil
Is SON overvalued? See what's priced in →
478 institutional managers reported holding SON in 13F filings for the quarter ended 2026-03-31. Together they hold about 86% of the company; the top 10 hold 48%. 69 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 9.7M shares were sold short as of the 2026-06-15 count, about 10% of shares outstanding (7.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
SON has cut its share count 0.8% over the past five years, spending $255.33M on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 16 years straight; the current rate is $2.11 a share annually. Cash returned over the past three years: $563.73M in dividends and $27.14M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at SON over the trailing three years: 2025: 13 buys totaling $4.05M. 14 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
SON's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-03 | -1.0% | -7.3% |
| 2023-11-03 | +5.1% | +5.1% |
| 2024-02-29 | -0.7% | -2.0% |
| 2024-05-02 | -0.9% | -10.8% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
SON's latest 8-K filings: 2026-08-05 (items 7.01, 9.01); 2026-07-22 (items 2.02, 9.01); 2026-05-11 (items 5.02); 2026-04-21 (items 2.02, 9.01); 2026-04-16 (items 5.07).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 11, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.